Vincerx Pharma (VINC)
(Delayed Data from NSDQ)
$0.75 USD
0.00 (-0.03%)
Updated Jul 5, 2024 04:00 PM ET
After-Market: $0.75 0.00 (0.03%) 7:58 PM ET
2-Buy of 5 2
F Value A Growth A Momentum C VGM
Brokerage Reports
0 items in cart
Vincerx Pharma, Inc. [VINC]
Reports for Purchase
Showing records 1 - 6 ( 6 total )
Company: Vincerx Pharma, Inc.
Industry: Medical - Biomedical and Genetics
Company: Vincerx Pharma, Inc.
Industry: Medical - Biomedical and Genetics
4Q 2021 Results; Significant Progress in 2021 and 2022. Reiterate Buy and Increasing our PT from $25 to $28
Provider: H.C. Wainwright & Co., Inc.
Analyst: KING M
Company: Vincerx Pharma, Inc.
Industry: Medical - Biomedical and Genetics
Preclinical Data on Selective CDK9 Inhibitor, VIP152, to be Presented at AACR; Reiterate Buy and $25 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: KING M
Company: Vincerx Pharma, Inc.
Industry: Medical - Biomedical and Genetics
VIP236 Targets Cancer Cells and Protects Healthy Tissue From Chemo; Reiterate Buy and $25 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: KING M
Company: Vincerx Pharma, Inc.
Industry: Medical - Biomedical and Genetics
Do You C What We C(DK)? Initiating at Buy and Price Target of $25
Provider: H.C. Wainwright & Co., Inc.
Analyst: KING M
Company: Vincerx Pharma, Inc.
Industry: Medical - Biomedical and Genetics
|